Peter W. Sonsini's Net Worth

$898 Million

Who is Peter W. Sonsini?

Peter W. Sonsini has an estimated net worth of $898 Million. This is based on reported shares across multiple companies, which include Desktop Metal, Inc., Cascadian Therapeutics, Inc., Arcellx, Inc., MULESOFT, INC, Robinhood Markets, Inc., Nkarta, Inc., Berkshire Grey, Inc., Bright Health Group Inc., Verona Pharma plc, Monte Rosa Therapeutics, Inc., Oyster Point Pharma, Inc., AVEO PHARMACEUTICALS, INC., APPIAN CORP, Mersana Therapeutics, Inc., Mirum Pharmaceuticals, Inc., Adaptimmune Therapeutics PLC, IonQ, Inc., Nightstar Therapeutics plc, Loxo Oncology, Inc., CHAMPIONS ONCOLOGY, INC., Surface Oncology, Inc., Reneo Pharmaceuticals, Inc., GENOCEA BIOSCIENCES, INC., Metacrine, Inc., Inozyme Pharma, Inc., Millendo Therapeutics, Inc., Eargo, Inc., ARDELYX, INC., Galera Therapeutics, Inc., Savara Inc, Trevi Therapeutics, Inc., Tracon Pharmaceuticals, Inc., Annexon, Inc., SYNLOGIC, INC., Akouos, Inc., Black Diamond Therapeutics, Inc., Arsanis, Inc., Cerecor Inc., Regulus Therapeutics Inc., ARCA biopharma, Inc., IMARA Inc., Marker Therapeutics, Inc., Casper Sleep Inc., ZeroFox Holdings, Inc., Senti Biosciences, Inc.\, Strongbridge Biopharma plc, Achaogen Inc, Tintri, Inc., and INTERLEUKIN GENETICS INC.

SEC CIK

Peter W. Sonsini's CIK is 0001559807

Past Insider Trading and Trends

2018 was Peter W. Sonsini's most active year for acquiring shares with 48 total transactions. Peter W. Sonsini's most active month to acquire stocks was the month of May. 2021 was Peter W. Sonsini's most active year for disposing of shares, totalling 52 transactions. Peter W. Sonsini's most active month to dispose stocks was the month of December. 2022 saw Peter W. Sonsini paying a total of $378,949,994.40 for 18,621,526 shares, this is the most they've acquired in one year. In 2019 Peter W. Sonsini cashed out on 78,321,254 shares for a total of $169,898,090.01, their largest year based on trade value.